Key Matters Approved by the Board

  • Audited Standalone Financial Results: The Board approved and took on record the Audited Standalone Financial Results for the fourth quarter and financial year ended March 31, 2026.
  • Auditor's Report: The Board noted the Independent Auditor's Report from M/s. Mahesh Udhwani & Associates on the aforementioned financial results.
  • Management Declaration: The Board noted a declaration from the Managing Director confirming the statutory auditors issued an audit report with an unmodified opinion on the financial results.
  • Appointment of CFO: Based on recommendations from the Audit Committee and Nomination and Remuneration Committee, the Board approved the appointment of Ms. Harshita Kharva (Chartered Accountant, Membership No. 641390) as the Chief Financial Officer (CFO) and Key Managerial Personnel (KMP) of the company, effective from May 30, 2026. Her brief profile was provided, highlighting experience in audit, taxation, and financial reporting.
  • Update to KMP List for Materiality: The Board approved an update to the list of Key Managerial Personnel authorized for determining materiality and making disclosures under Regulation 30(5) of the Listing Regulations. The updated list of contacts is:
  • Mr. Gaurav Jayant Gupte, Managing Director (ayokimerchantile@gmail.com)
  • Mr. Yuvraj Priyadarshi, CEO cum Director (dr.yuvraj@wardwizardmed.com)
  • Ms. Harshita Kharva, Chief Financial Officer (ayokiacc@gmail.com)
  • Ms. Rajbala Kiroriwal, Company Secretary and Compliance Officer (ayoki1985@gmail.com)

Detailed Financial Results (Standalone)

All figures are in Indian Rupees (₹ Lakhs)

Profit & Loss Statement Highlights

For the Year Ended March 31, 2026 (Audited):

  • Total Income: ₹169.70
  • Total Expenses: ₹324.35
  • Loss Before Tax: ₹(282.48)
  • Tax Expense: ₹(11.16)
  • Net Loss for the Year: ₹(271.33)
  • Other Comprehensive Income (Net of Tax): ₹3.22
  • Total Comprehensive Income for the Year: ₹(271.33)

For the Quarter Ended March 31, 2026 (Audited):

  • Total Income: ₹11.29
  • Total Expenses: ₹126.11
  • Loss Before Tax: ₹(114.83)
  • Tax Expense: ₹(4.02)
  • Net Loss for the Quarter: ₹(110.81)
  • Other Comprehensive Income (Net of Tax): ₹0.26
  • Total Comprehensive Income for the Quarter: ₹(110.81)

Earnings Per Share (EPS) - Basic and Diluted:

  • FY2026: ₹(110.75)
  • Q4 FY2026: ₹(45.23)

Balance Sheet Highlights (As of March 31, 2026, Audited)

  • Total Assets: ₹103.84 Lakhs (Previous Year: ₹874.11 Lakhs)
  • Property, Plant and Equipment: ₹15.81 Lakhs (PY: ₹727.82 Lakhs)
  • Trade Receivables: ₹76.79 Lakhs (PY: ₹0.28 Lakhs)
  • Cash and Cash Equivalents: ₹1.35 Lakhs (PY: ₹2.76 Lakhs)
  • Total Equity: ₹(339.59) Lakhs (Negative Equity) (PY: ₹(311.29) Lakhs)
  • Total Liabilities: ₹443.44 Lakhs (PY: ₹1,185.40 Lakhs)
  • Borrowings (Current): ₹313.01 Lakhs (PY: ₹274.82 Lakhs)
  • Lease Liability (Current): ₹11.11 Lakhs (PY: ₹71.35 Lakhs)
  • Paid-up Equity Share Capital: ₹24.50 Lakhs (Face Value ₹10/- each)

Cash Flow Statement Highlights (For the Year Ended March 31, 2026, Audited)

  • Net Cash Used in Operating Activities: ₹(11.51) Lakhs
  • Net Cash Used in Investing Activities: ₹(7.60) Lakhs
  • Net Cash Generated from Financing Activities: ₹17.70 Lakhs
  • Net Decrease in Cash and Equivalents: ₹(1.41) Lakhs
  • Cash and Equivalents at Year-End: ₹1.35 Lakhs

Additional Regulatory Disclosures

  • Declaration of Unmodified Opinion: A separate declaration signed by Managing Director Gaurav Jayant Gupte was submitted to BSE, confirming the auditors issued an unmodified opinion on the financial results, as required by Regulation 33(3)(d).
  • Large Corporate Status: The company disclosed that it is not identified as a 'Large Corporate' as of March 31, 2026, under SEBI's framework for fundraising via debt securities. Outstanding and incremental qualified borrowings during the year were nil.
  • Investor Complaints: No investor complaints remained pending as of the quarter ended March 31, 2026.
  • Business Segment: The company is primarily engaged in medical and healthcare-related services and has only one reportable segment.

Meeting Logistics

  • The Board meeting commenced at 9:00 PM and concluded at 10:05 PM on May 30, 2026.

#Tags: #WardwizardHealthcare #FY2026Results #SEBIDisclosure #RegulatoryCompliance #FinancialUpdate #Negative